Search
Research
The seroprevalence of SARS-CoV-2-specific antibodies in children, Australia, November 2020 - March 2021Peter Britta Richmond Regli-von Ungern-Sternberg AM FAHMS MBBS MRCP(UK) FRACP MD, PhD, DEAA, FANZA Head, Vaccine Trials Group Chair of Paediatric
Research
Examining the interseasonal resurgence of respiratory syncytial virus in Western AustraliaFollowing a relative absence in winter 2020, a large resurgence of respiratory syncytial virus (RSV) detections occurred during the 2020/2021 summer in Western Australia. This seasonal shift was linked to SARS-CoV-2 public health measures. We examine the epidemiology and RSV testing of respiratory-coded admissions, and compare clinical phenotype of RSV-positive admissions between 2019 and 2020.
Research
Do rapid diagnostic methods improve antibiotic prescribing in paediatric bacteraemia?Rapid blood culture pathogen identification facilitated by matrix-assisted laser desorption ionisation time-of-flight and GeneXpert has the potential to improve antibiotic prescribing. This study investigates the impact of these rapid diagnostics on the timeliness of effective and optimal antibiotic prescribing in paediatric patients with bacteraemia.

News & Events
The Kids researchers named as finalists in 2020 Premier’s Science AwardsTwo The Kids Research Institute Australia researchers have been named as finalists in the 2020 Western Australian Premier’s Science Awards.

News & Events
New Co-directors for the Wesfarmers Centre of Vaccines and Infectious DiseasesDr Lea-Ann Kirkham and Dr Chris Blyth have been appointed as Co-Directors


News & Events
Top honour for infectious diseases researchCongratulations to Associate Professor Asha Bowen, who has been awarded the 2022 Frank Fenner Award for Advanced Research in Infectious Diseases.

We are looking for children to take part in an important study that will assess a new treatment designed to prevent ongoing ear infections in kids having grommet surgery.
The Kids Research Institute Australia is looking for healthy babies (born from 35 weeks of pregnancy onwards) to take part in an important study evaluating a new medication that may help prevent Respiratory Syncytial Virus (RSV) disease.
Whooping Cough Study in Young Adults could lead to an effective “stand alone” vaccine for Australians